back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-04-09 10:52 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,500 vol |
0 | |
| Filed 2023-04-09 10:38 Tx date 2021-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
4,000 | |
| Filed 2023-03-30 11:34 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,375
+2,500 vol $3.75 each |
251,540 | |
| Filed 2022-04-04 19:05 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,500 vol |
0 | |
| Filed 2022-04-04 19:05 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,225
+2,500 vol $2.09 each |
249,040 | |
| Filed 2022-03-30 14:28 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
2,500 | |
| Filed 2022-03-30 14:27 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,850
+5,000 vol $2.17 each |
34,021 | |
| Filed 2021-06-04 10:34 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2021-05-26 10:17 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,575
+1,500 vol $1.05 each |
246,540 | |
| Filed 2020-05-29 16:41 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+478 vol |
245,040 | |
| Filed 2020-05-29 16:40 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-866 vol |
1,500 | |
| Filed 2020-05-11 16:46 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
2,366 | |
| Filed 2020-05-11 16:44 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,150
+3,500 vol $0.90 each |
29,021 | |
| Filed 2019-08-24 22:33 Tx date 2019-08-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,674
+24,800 vol $0.95 each |
244,562 | |
| Filed 2019-08-24 22:30 Tx date 2019-08-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,492
+11,200 vol $0.94 each |
219,762 | |
| Filed 2019-08-24 22:29 Tx date 2019-08-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,046
+18,200 vol $0.94 each |
208,562 | |
| Filed 2019-08-24 22:28 Tx date 2019-08-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,015
+18,000 vol $0.95 each |
190,362 | |
| Filed 2019-08-21 17:19 Tx date 2019-08-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,704
+17,300 vol $1.20 each |
172,362 | |
| Filed 2019-08-21 17:18 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$59,200
+50,000 vol $1.18 each |
155,062 | |
| Filed 2019-04-23 22:24 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+866 vol |
866 | |
| Filed 2019-04-23 22:23 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,991
+2,021 vol $1.48 each |
25,521 | |
| Filed 2019-04-17 12:32 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-17 11:46 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2019-04-17 11:46 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-17 11:45 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+762 vol |
105,062 | |
| Filed 2019-04-17 11:43 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2019-04-17 11:43 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
104,300 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,355
+3,500 vol $3.53 each |
23,500 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2017-05-26 Tx date 2017-05-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-26 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2017-05-19 Tx date 2017-05-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$101,199
+20,000 vol $5.06 each |
20,000 | |
| Filed 2017-05-16 Tx date 2017-05-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
102,800 |